ACTG Publications

TitleAuthorsDateJournalIssueVolume
Hemodialysis does not significantly affect the pharmacokinetics of nevirapine in HIV-1-infected persons requiring hemodialysis: results from ACTG A5177.Cramer, Yoninah S ; Rosenkranz, Susan L ; Hall, Stephen D ; Szczech, Lynda A ; Amorosa, Valerianna ; Gupta, Samir K2010 AugJ Acquir Immune Defic Syndr454
The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis.Gupta, Samir K ; Rosenkranz, Susan L ; Cramer, Yoninah S ; Koletar, Susan L ; Szczech, Lynda A ; Amorosa, Valerianna ; Hall, Stephen D2008 Oct 1AIDS1522
Safety and antiviral activity of the HCV entry inhibitor ITX5061 in treatment-naive HCV-infected adults: a randomized, double-blind, phase 1b study.Sulkowski, Mark S ; Kang, Minhee ; Matining, Roy ; Wyles, David ; Johnson, Victoria A ; Morse, Gene D ; Amorosa, Valerianna ; Bhattacharya, Debika ; Coughlin, Kristine ; Wong-Staal, Flossie ; Glesby, Marshall J ; AIDS Clinical Trials Group A5277 Protocol Team2014 Mar 1J Infect Dis5209